United States - English - NLM (National Library of Medicine)

direct_rx - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), menthol, unspecified form (unii: l7t10eip3a) (menthol, unspecified form - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - topical analgesic temporary relief of minor aches and pains of muscles and joints associated with:• simple backache • arthritis • muscle strains • sprains • bruises

United States - English - NLM (National Library of Medicine)

proficient rx lp - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol, unspecified form (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - methyl salicylate 20 g in 100 g - purpose topical analgesic topical anesthetic uses: for the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, muscle soreness and stiffness. do not use: on wounds or damaged skin. children under 12 years old, consult a doctor. if you are allergic to any ingredients in this product.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), menthol, unspecified form (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - capsaicin .000325 g in 1 g - topical analgesic topical analgesic topical analgesic topical analgesic temporarily relieves minor aches and muscles pains associated with:

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), menthol, unspecified form (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - topical analgesic topical analgesic topical analgesic topical analgesic temporarily relieves minor aches and muscles pains associated with:

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), menthol, unspecified form (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - counterirritant topical anesthetic topical analgesic counterirritant for the temporary relief of joint pain and muscle pain associated with:

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), menthol, unspecified form (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - topical analgesic temporarily relieves mild aches and pains of muscles or joints.

United States - English - NLM (National Library of Medicine)

pharmaplast sae - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - capsaicin 0.6 mg - topical analgesic temporarily relieves minor pain associated with: - arthritis - simple backache - strains - sprains - bruises - on wounds or damaged skin - with or at the same time as other external analgesic products - conditions worsens - symptoms persist more than 7 days or clear up and occur again within a few days - rash, itching or excessive skin irritation develops

United States - English - NLM (National Library of Medicine)

acorda therapeutics, inc. - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - capsaicin 640 ug in 1 cm2 - qutenza is indicated for the management of neuropathic pain associated with postherpetic neuralgia. none. teratogenic effects: pregnancy category b there are no adequate and well-controlled studies evaluating qutenza in pregnant women. there was no evidence of fetal teratogenicity in embryofetal developmental toxicological studies conducted in pregnant rats and rabbits in which qutenza patches (rats) or liquid (rabbits) were applied once daily for a 3 hour duration during the period of fetal organogenesis up to doses corresponding to an 11-fold (rat, 32 mg capsaicin patch/day) and 37-fold (rabbit, 260 mg capsaicin/day) margin over the maximum recommended human dose [mrhd] based on a c max exposure comparison. in a peri- and post-natal reproduction toxicology study, pregnant female rats were treated with qutenza patches at doses up to 32 mg capsaicin patch/rat/day applied once daily for a 3 hours duration during gestation and lactation (from gestation day 7 through day 28 postpartum). analyses of milk samples

Canada - English - Health Canada

wex pharmaceuticals inc - capsaicin - cream - 0.025% - capsaicin 0.025% - basic lotions and liniments

Canada - English - Health Canada

wex pharmaceuticals inc - capsaicin - cream - 0.05% - capsaicin 0.05% - basic lotions and liniments